Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

DMAA

Drugs Made In America Acquisition Corp.

CIK 0002028614 · Nasdaq

NasdaqFinancialsBlank Checks
$10.75
↑ 0.03 (0.23%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$260.98M
P/E Ratio
42.82
EPS
Not covered
Dividend Yield
Not covered
52W Position
100%
Beta
0.00

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-35.24
P/S
Not covered
EV/Revenue
Not covered
ROE
-82.3%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 100%
$10.22$10.75

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
$5.94M
Total Assets
$239.92M
Free Cash Flow
–

Recent news